No abstract available
MeSH terms
-
Animals
-
Anticoagulants / therapeutic use
-
Antiviral Agents / therapeutic use
-
Betacoronavirus / drug effects
-
Betacoronavirus / pathogenicity*
-
Blood Coagulation Disorders / blood
-
Blood Coagulation Disorders / drug therapy
-
Blood Coagulation Disorders / epidemiology
-
Blood Coagulation Disorders / virology*
-
Blood Coagulation* / drug effects
-
COVID-19
-
COVID-19 Drug Treatment
-
Coronavirus Infections / blood
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / virology*
-
Host-Pathogen Interactions
-
Humans
-
Pandemics
-
Pneumonia, Viral / blood
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / virology*
-
Practice Guidelines as Topic
-
Risk Assessment
-
Risk Factors
-
SARS-CoV-2
-
Treatment Outcome
-
Viral Load
Substances
-
Anticoagulants
-
Antiviral Agents